Sun.Jul 02, 2023

article thumbnail

New patent expiration for Bayer Hlthcare drug LEVITRA

Drug Patent Watch

Annual Drug Patent Expirations for LEVITRA Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug and three Paragraph… The post New patent expiration for Bayer Hlthcare drug LEVITRA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

CMS tweaks Medicare price negotiation but remains defiant

pharmaphorum

CMS tweaks Medicare price negotiation but remains defiant Phil.

88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Eyepoint Pharms drug DEXYCU KIT

Drug Patent Watch

Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are seven… The post New patent expiration for Eyepoint Pharms drug DEXYCU KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Gilead, Teva cleared in $3.6bn ‘pay-for-delay’ trial

pharmaphorum

Gilead, Teva cleared in $3.6bn ‘pay-for-delay’ trial Phil.

Trials 88
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

New tentative approval for Mylan Labs drug posaconazole

Drug Patent Watch

[![posaconazole structure]([link] Posaconazole is the generic ingredient in three branded drugs marketed by Msd Merck Co, Merck Sharp Dohme, Par Sterile Products, Schering, Hikma, Actavis Labs Fl Inc, Aet Pharma,… The post New tentative approval for Mylan Labs drug posaconazole appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Trends in Mortality From Poisonings, Firearms, and All Other Injuries by Intent

JAMA Internal Medicine

This cross-sectional study reports trends in mortality from poisonings, firearms, and all other injuries by intent in US adults from 1999 to 2020.

53

More Trending

article thumbnail

JAMA Internal Medicine —Providing Compelling, Credible, Timely, and Essential Evidence

JAMA Internal Medicine

We live in a time of breathtaking advances in biomedicine. During my lifetime, scientific breakthroughs have made previously fatal or debilitating diseases treatable with revolutionary new drugs or molecularly targeted approaches for AIDS, hepatitis, cancer, and many other conditions across the full spectrum of internal medicine. Medical discovery has also helped set the stage for the highly accelerated development of the COVID-19 vaccine—one of the greatest scientific achievements in history.

article thumbnail

WHO Regional Adviser for Prevention and Response to sexual misconduct in South-East Asia

The Pharma Data

WHO Regional Adviser for Prevention and response to sexual misconduct in South-East Asia Anju Pandey is a feminist, humanist and gender trainer. She joined WHO’s Regional Office for South-East Asia as a Regional Advisor on prevention and response to sexual misconduct (PRS) in March 2023. This followed a long career as a development practitioner and gender specialist, as well as a decade at UN Women, where she worked on promoting gender equality and women’s empowerment.

article thumbnail

Which pharmaceutical companies have the most film dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most film dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most film dosed drugs… The post Which pharmaceutical companies have the most film dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Syneos Health Strengthens Asia Pacific Leadership

The Pharma Data

Syneos Health Strengthens Asia Pacific Leadership Syneos Health ® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Shigeto Miyamoto as Vice President of Digital Solutions for Asia Pacific. In this new role, Shigeto will drive commercial customer growth and the Company’s digital and analytical capabilities and service offerings in the region.

Sales 40
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations